Why is Nectar Lifesci. falling/rising?

As of 04-Aug, Nectar Lifescience Ltd is experiencing a decline in its stock price, currently at Rs. 15.54, which represents a decrease of 0.71 or 4.37%. The stock has hit a new 52-week low of Rs. 15.49 today and has underperformed its sector by 5.02%. Over the past three days, the stock has consistently fallen, accumulating a total decline of 6.69%. Additionally, the stock has shown significant underperformance against the benchmark, with a one-week return of -6.95% compared to the Sensex's slight gain of 0.16%. The company's financial health is concerning, as it has reported operating losses and a high Debt to EBITDA ratio of 7.73 times, indicating a weak ability to service its debt. The recent quarterly profit after tax has plummeted by 3160.9%, and the return on capital employed is at its lowest, further contributing to the stock's negative sentiment.
In the broader market context, Nectar Lifescience Ltd's performance has been consistently poor compared to the benchmark over the last three years, with a one-year return of -51.29% against a negligible gain of 0.05% for the Sensex. This consistent underperformance, coupled with the fact that 99.6% of promoter shares are pledged, adds to the downward pressure on the stock price, particularly in a falling market. The liquidity of the stock is also a concern, as delivery volume has decreased significantly, indicating waning investor interest. Overall, the combination of weak financial fundamentals, high debt levels, and negative market sentiment is driving the stock's decline.